StockData

Heartflow vs Kestra Medical Technologies

HTFL and KMTS side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HTFL and KMTS compare

Heartflow is the larger company, worth 2.5 times as much as Kestra Medical Technologies ($4.2B against $1.7B).

Kestra Medical Technologies grew revenue faster over the last twelve months (60.7% versus 47.4% for Heartflow).

Heartflow keeps more of each dollar of sales as profit, with a net margin of −33.1% compared with −140% at Kestra Medical Technologies.

Heartflow scores higher on the StockData Score (9 against 5 for Kestra Medical Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHTFLKMTS
Size and price
Market cap$4.2B$1.7B
Share price$48.46$28.64
Change, 1 year35.6%6.9%
Beta (5Y)1.701.21
Employees843443
StockData Score
Total score9 (better)5
Valuation score00
Growth score33
Performance score1 (better)0
Health score5 (better)2
Dividend score00
Valuation
P/S17.7×16.0× (better)
P/B14.9×–
FCF yield−1.3% (better)−7.2%
Fair value$9.03–
Margin of safety−437%–
Growth
Revenue growth (TTM)47.4%60.7% (better)
Profitability
Gross margin81.8% (better)53.9%
Operating margin−33.1% (better)−134%
Net margin−33.1% (better)−140%
FCF margin−23.5% (better)−115%
Return on equity−29.4%–
Financial health
Debt / equity0.00–
Interest coverage−4937.5×−19.0× (better)
Current ratio4.414.69 (better)
Altman Z-score30.78 (better)4.94
Piotroski F-score6 (better)4
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions86.0%98.6%
Held by insiders58.7%44.0%
Insider net buying, 12 months−$143M−$15.3M (better)
Short interest, % of float15.9%12.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.